Mayne Pharma Group Ltd (MYX.AX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 06/30
| 06-2015 | 06-2014 | 06-2013 | 06-2012 | 06-2011 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 59,201 | 14,813 | 18,938 | 11,596 | 5,901 |
| Marketable Securities | 2,229 | 1,172 | 1,825 | N/A | N/A |
| Receivables | 64,657 | 29,805 | 25,328 | 4,615 | 6,366 |
| Inventories | 22,444 | 17,236 | 27,186 | 14,488 | 12,846 |
| Income taxes - deferred | 2,956 | 1,023 | 1,596 | N/A | 630 |
| Other current assets | 0 | 0 | 1,335 | 659 | 281 |
| TOTAL | $156,820 | $65,895 | $77,543 | $31,887 | $26,305 |
| Non-Current Assets | |||||
| PPE Net | 59,597 | 53,409 | 83,163 | 33,009 | 32,465 |
| Investments And Advances | N/A | 4,076 | N/A | N/A | N/A |
| Intangibles | 302,960 | 141,115 | 115,470 | 4,585 | 8,574 |
| Other Non-Current Assets | 9,569 | 1,325 | 976 | 4,260 | 5,199 |
| TOTAL | $372,126 | $199,925 | $199,609 | $41,854 | $46,238 |
| Total Assets | $528,946 | $265,820 | $277,152 | $73,741 | $72,543 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | 2,374 | 7,471 | N/A | 4,678 |
| Accounts payable and accrued liabilities | 51,572 | 7,131 | 10,504 | 4,234 | 3,848 |
| Other current liabilities | 26,811 | 3,953 | 18,130 | 2,782 | 5,837 |
| TOTAL | $95,078 | $30,379 | $51,573 | $13,645 | $19,042 |
| Non-Current Liabilities | |||||
| Long Term Debt | 61,756 | 45,656 | 39,227 | N/A | N/A |
| Other Non-Current Liabilities | -2,775 | 8,726 | 10,881 | 7,299 | 10,086 |
| TOTAL | $111,666 | $76,167 | $70,678 | $11,029 | $14,564 |
| Total Liabilities | $206,744 | $106,546 | $122,251 | $24,674 | $33,606 |
| Shareholders' Equity | |||||
| Common Shares | 255,834 | 137,498 | 118,302 | 32,016 | 31,870 |
| Retained earnings | 24,175 | 16,416 | -4,874 | -2,503 | -8,656 |
| Other shareholders' equity | 30,861 | 5,360 | 7,461 | 1,087 | 1,920 |
| TOTAL | $310,870 | $159,274 | $120,889 | $30,600 | $25,134 |
| Total Liabilities And Equity | $517,614 | $265,820 | $243,140 | $55,274 | $58,740 |